InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,240.03
(
1.04%
)
US TECH 100
17,825.20
(
1.39%
)
Dow Jones
38,997.66
(
0.76%
)
Brent Oil
77.39
(
1.80%
)
Bitcoin
57,671.48
(
2.89%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: ridinbulls post# 89239

Wednesday, 07/22/2015 9:23:56 AM

Wednesday, July 22, 2015 9:23:56 AM

Post# of 97239
$AVXL..agree. The data is encouraging data just wanted to see it on a larger scale of patients. That will be even more impactful then where as now still lots of unknowns. Same thing we always have until we have Phase 3 data. That is more important than ever in Alzheimer's disease where we have had so many drug failure candidates.

Message in reply to:

AVXL...The trial has not progressed far enough for the data on the other patients perhaps? Your thoughts?

Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up